AssetMark Inc’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$63.8M Buy
815,888
+170,741
+26% +$13.8M 0.11% 159
2026
Q1
$55.9M Buy
645,147
+58,596
+10% +$5.61M 0.11% 155
2025
Q4
$56.3M Buy
586,551
+93,338
+19% +$9.07M 0.11% 149
2025
Q3
$47M Buy
493,213
+74,948
+18% +$6.89M 0.1% 164
2025
Q2
$36.5M Buy
418,265
+98,811
+31% +$8.38M 0.09% 185
2025
Q1
$28.7M Buy
319,454
+32,193
+11% +$2.88M 0.08% 202
2024
Q4
$22.9M Buy
287,261
+36,760
+15% +$3.18M 0.06% 229
2024
Q3
$22.6M Buy
250,501
+5,210
+2% +$438K 0.06% 218
2024
Q2
$19.3M Sell
245,291
-405
-0.2% -$33.2K 0.06% 229
2024
Q1
$21.4M Buy
245,696
+4,046
+2% +$345K 0.07% 208
2023
Q4
$19.9M Buy
241,650
+5,980
+3% +$456K 0.07% 208
2023
Q3
$18.5M Buy
235,670
+9,623
+4% +$806K 0.07% 195
2023
Q2
$19.9M Buy
226,047
+6,565
+3% +$565K 0.08% 191
2023
Q1
$17.7M Buy
219,482
+22,406
+11% +$1.83M 0.07% 191
2022
Q4
$15.3M Buy
197,076
+23,027
+13% +$1.87M 0.07% 200
2022
Q3
$14.1M Buy
174,049
+25,687
+17% +$2.31M 0.07% 191
2022
Q2
$13.3M Buy
148,362
+23,873
+19% +$2.42M 0.06% 203
2022
Q1
$13.8M Buy
124,489
+13,050
+12% +$1.38M 0.06% 204
2021
Q4
$11.5M Buy
111,439
+4,509
+4% +$522K 0.05% 212
2021
Q3
$13.4M Buy
106,930
+354
+0.3% +$45.8K 0.06% 201
2021
Q2
$13.2M Buy
106,576
+4,268
+4% +$536K 0.06% 207
2021
Q1
$12.1M Buy
102,308
+297
+0.3% +$34.8K 0.06% 205
2020
Q4
$11.9M Buy
102,011
+1,860
+2% +$205K 0.07% 204
2020
Q3
$10.4M Buy
100,151
+820
+0.8% +$82.3K 0.07% 192
2020
Q2
$9.24M Sell
99,331
-24,434
-20% -$2.34M 0.07% 195
2020
Q1
$11.2M Buy
123,765
+29,320
+31% +$3.12M 0.09% 159
2019
Q4
$10.7M Buy
94,445
+90,815
+2,502% +$9.97M 0.08% 192
2019
Q3
$394K Sell
3,630
-155
-4% -$16.2K ﹤0.01% 400
2019
Q2
$369K Sell
3,785
-109
-3% -$9.95K ﹤0.01% 394
2019
Q1
$355K Buy
3,894
+291
+8% +$26K ﹤0.01% 386
2018
Q4
$328K Buy
3,603
+1,590
+79% +$149K ﹤0.01% 382
2018
Q3
$198K Sell
2,013
-165
-8% -$15.3K ﹤0.01% 461
2018
Q2
$186K Buy
2,178
+52
+2% +$4.34K ﹤0.01% 461
2018
Q1
$171K Sell
2,126
-3,852
-64% -$318K ﹤0.01% 470
2017
Q4
$483K Buy
5,978
+1,812
+43% +$145K 0.01% 363
2017
Q3
$324K Sell
4,166
-206
-5% -$17.1K ﹤0.01% 399
2017
Q2
$388K Buy
4,372
+37
+0.9% +$3.12K ﹤0.01% 366
2017
Q1
$349K Buy
4,335
+230
+6% +$18K ﹤0.01% 365
2016
Q4
$292K Sell
4,105
-87
-2% -$6.83K ﹤0.01% 371
2016
Q3
$362K Buy
4,192
+553
+15% +$48.2K 0.01% 335
2016
Q2
$316K Sell
3,639
-873
-19% -$70.6K 0.01% 346
2016
Q1
$338K Sell
4,512
-863
-16% -$65K 0.01% 336
2015
Q4
$413K Buy
5,375
+5,273
+5,170% +$397K 0.01% 366
2015
Q3
$7K Buy
102
+5
+5% +$368 ﹤0.01% 522
2015
Q2
$7K Buy
97
+33
+52% +$2.52K ﹤0.01% 553
2015
Q1
$5K Buy
+64
New +$4.85K ﹤0.01% 443
2014
Q3
Sell
-26,311
Closed -$1.68M 495
2014
Q2
$1.68M Buy
+26,311
New +$1.6M 0.04% 234

Other funds holding MDT

AssetMark Inc's MDT Position: Q2 2026 in Review

AssetMark Inc increased its Medtronic (MDT) stake by 26% in Q2 2026, buying an estimated $13.8M and bringing the position to 815,888 shares worth $63.8M. The position accounts for 0.11% of the portfolio, ranked #159.

AssetMark Inc first reported a position in MDT in Q2 2014 and has held it in 47 quarters since. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • AssetMark Inc held 815,888 shares of Medtronic worth $63.8M as of Q2 2026.
  • AssetMark Inc bought 170,741 Medtronic shares in Q2 2026, an estimated $13.8M.
  • Medtronic made up 0.11% of AssetMark Inc's portfolio in Q2 2026, its #159 holding.
  • AssetMark Inc first reported a position in Medtronic in Q2 2014 and has held it in 47 quarters since.
  • 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.